Critical lessons from the ENHANCE trial

JAMA

Volumn 299, Issue 8, 2008, Pages 953-955

  Greenland, Philip ^a   Lloyd Jones, Donald ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EZETIMIBE PLUS SIMVASTATIN; LOW DENSITY LIPOPROTEIN; SIMVASTATIN; AZETIDINE DERIVATIVE; EZETIMIBE; HYPOCHOLESTEROLEMIC AGENT;

CAROTID ARTERY; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG INDUSTRY; DRUG INFORMATION; EVIDENCE BASED MEDICINE; EVIDENCE BASED PRACTICE; FAMILIAL HYPERCHOLESTEROLEMIA; HEART DEATH; HEART INFARCTION; HUMAN; MASS MEDIUM; MEDICAL DECISION MAKING; MONOTHERAPY; NOTE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; SIDE EFFECT; STROKE; TREATMENT OUTCOME; ARTICLE; ATHEROSCLEROSIS; CONFLICT OF INTEREST; DRUG APPROVAL; ECHOGRAPHY; HYPERLIPOPROTEINEMIA TYPE 1; STATISTICAL ANALYSIS;

ANTICHOLESTEREMIC AGENTS; ATHEROSCLEROSIS; AZETIDINES; CAROTID ARTERIES; CONFLICT OF INTEREST; DATA INTERPRETATION, STATISTICAL; DRUG APPROVAL; DRUG INDUSTRY; HUMANS; HYPERLIPOPROTEINEMIA TYPE I; MASS MEDIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SIMVASTATIN;

EID: 40349092788     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.299.8.953     Document Type: Note

References (16)

1. Schering-Plough Web site. Merck/Schering-Plough Pharmaceuticals provides results of the ENHANCE trial [January 14, 2008, news release]. http://www.schering-plough.com/schering_plough/news/release.jsp?releaseID= 1095943. Accessed January 15, 2008.
2. Hodis HN, Mack WJ, LaBree L, et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med. 1998;128(4):262-269.
3. Kumar A, Cannon CP. Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary intervention. J Interv Cardiol. 2007;20(6):447-457.
4. Heart.org Web site. Vytorin receives FDA approval amid controversy over its role. http://www.theheart.org/article/126469.do. Accessed January 27, 2008.
5. Laine C, Horton R, DeAngelis CD, et al. Clinical trial registration: looking back and moving ahead. JAMA. 2007;298(1):93-94.
6. Carey J. Do cholesterol drugs do any good? Business Week. January 28, 2008: 52-59.
7. Taubes G. What's cholesterol got to do with it? New York Times. January 27, 2008:Opinion18.
8. National Cholesterol Education Program Expert Panel on Detection. Evaluation, and Treatment of High Blood Cholesterol in Adults. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report. Circulation. 2002;106(25):3143-3421.
9. Lewington S, Whitlock G, Clarke R, et al; Prospective Studies Collaboration. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a metaanalysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007;370(9602):1829-1839.
10. Baigent C, Keech A, Kearney PM, et al; Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366(9493):1267-1278.
11. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358(3):252-260.
12. Saul S. Group with industry ties backs drug. New York Times. January 24, 2008:C1, C4.
13. Parker-Pope T. What that cholesterol trial showed, and what it didn't. New York Times. January 22, 2008;D1, D6.
14. Winslow R, Rubenstein S. Study deals setback to Vytorin cholesterol drug. Wall Street Journal. January 15, 2008:A3.
15. American College of Cardiology Web site. ACC statement on ENHANCE trial. http://www.acc.org/enhance.htm. Accessed January 27, 2008.
16. American Heart Association Web site. Statement from the American Heart Association on ENHANCE study results. http://www.americanheart.org/presenter. jhtml?identifier=3053094. Accessed January 27, 2008.